(19)
(11) EP 1 297 147 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.02.2007 Bulletin 2007/08

(45) Mention of the grant of the patent:
27.12.2006 Bulletin 2006/52

(21) Application number: 01952368.7

(22) Date of filing: 28.06.2001
(51) International Patent Classification (IPC): 
C12N 15/38(2006.01)
C07K 14/035(2006.01)
A61K 38/16(2006.01)
G01N 33/571(2006.01)
 C12N 15/62(2006.01)
C07K 16/08(2006.01)
A61K 39/245(2006.01)
A61P 31/22(2006.01)
(86) International application number:
PCT/US2001/020981
(87) International publication number:
WO 2002/002131 (10.01.2002 Gazette 2002/02)

(54)

COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF HERPES SIMPLEX VIRUS INFECTION

ZUSAMMENSETZUNG ZUR DIAGNOSE UND BEHANDLUNG VON HERPES SIMPLEX VIRUSINFEKTIONEN

COMPOSITIONS POUR LE DIAGNOSTIC ET LE TRAITEMENT DE L'INFECTION DU VIRUS DE L'HERPES

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 29.06.2000 US 215458 P
20.03.2001 US 277438 P

(43) Date of publication of application:
02.04.2003 Bulletin 2003/14

(73) Proprietor: CORIXA CORPORATION
Hamilton, Montana 59840-3131 (US)

(72) Inventors:
  • HOSKEN, Nancy, A.
    Seattle, WA 98103 (US)
  • DAY, Craig, H.
    Seattle, WA 98133-8317 (US)
  • DILLON, Davin, C.
    Issaquah, WA 98027 (US)
  • MCGOWAN, Patrick
    Seattle, WA 98116 (US)
  • SLEATH, Paul, R.
    Seattle, WA 98119 (US)

(74) Representative: Walker, Ross Thomson 
Forrester & Boehmert, Pettenkoferstrasse 20-22
80336 München
80336 München (DE)


(56) References cited: : 
EP-A- 0 531 728
 WO-A-98/55145
   
  • DATABASE EMBL [Online] 1 October 1996 (1996-10-01) "HSV2 ribonucleotide reductase 136 kDa subunit (UL39)" retrieved from EMBL Database accession no. P09853 XP002187044
  • DATABASE EMBL [Online] 1 May 1997 (1997-05-01) "Herpes SImplex Virus type 2 tegument protein" retrieved from EMBL Database accession no. P89466 XP002201190
  • VERJANS G.M.G.M. ET AL.: "Intraocular T cells of patients with Herpes Simplex Virus (HSV)-induced acute retinal necrosis recognize HSV tegument proteins VP11/12 and VP13/14." J. INFECTIOUS DISEASES, vol. 182, September 2000 (2000-09), pages 923-927, XP002201189
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).